Home > Medical Reference > Patient Education

Services at Maryland General

A complete list of inpatient and outpatient healthcare services at MGH.

Alzheimer's disease

Description

An in-depth report on the causes, diagnosis, and treatment of Alzheimer's disease.


Highlights

Drug Name Change

Galantamine’s brand name is now Razadyne. In 2005, the manufacturer changed the name from Reminyl to avoid confusion with other drugs. Razadyne is indicated for treatment of mild-to-moderate Alzheimer’s disease.

Drug Research

  • Memantine (Namenda) is safe and helps in the treatment of moderate-to-severe Alzheimer’s disease, according to a 2006 study in the Archives of Neurology . Memantine is currently the only drug approved for treatment of the later stages of Alzheimer’s disease.
  • Newer antipsychotic drugs (aripiprazole, clozapine, olanzapine, quetiapine, risperidone, and ziprasidone) may not be safer than older antipsychotic drugs (haloperidol and chlorpromazine). According to a review in the Journal of the American Medical Association , newer antipsychotic drugs may slightly increase the risk of death in patients with Alzheimer’s disease.
  • Patients who take high blood pressure drugs may have a lower risk of developing Alzheimer’s disease, suggests a 2006 study in the Archives of Neurology . Researchers found that potassium-sparing diuretics offered the most protection. Beta-blockers and some types of calcium channel blockers were somewhat helpful, but ACE inhibitors had no effect on risk.
  • A 2006 study published in the New England Journal of Medicine found that there are no differences in treatment between placebo and Zyprexa, Seroquel, and Risperdal, antipsychotic drugs used to calm agitation in people with Alzheimer's.

Diet

The heart-protective Mediterranean diet may also help the brain. A 2006 study found that people who strictly followed the eating plan had a 40% lower risk of developing Alzheimer’s disease than people who ate a typical American diet. The Mediterranean diet emphasizes fish, fruits, vegetables, and monounsaturated fats such as olive and canola oils.

Exercise

Older adults who exercise at least three times a week might cut their risk of developing Alzheimer’s disease by 30 - 40%, suggests a study in the Annals of Internal Medicine . Patients in the study engaged in exercises that included walking, hiking, aerobics, swimming, and weight training.


  • Review Date: 5/22/2006
  • Reviewed By: Harvey Simon, M.D., Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
     
Physician Directory

Physician Specialties

Medical Glossary

Guide for Patients

Guide for Visitors

    
About Us     ·     Contact Us     ·     Phone Listing     ·     Residency Programs     ·     Site Map     ·     Site Search     ·     Links     ·     FAQs

© 2008 Maryland General Hospital, All Rights Reserved   ·   827 Linden Avenue,   Baltimore, MD 21201   ·   410-225-8000
Commitment to Compliance   ·   Privacy Policy   ·   Terms and Conditions of Use   ·   Disclaimer   ·   JCAHO Public Notice